The pathogenesis of rheumatoid arthritis remains unknown, Disease modi
fying anti-rheumatic drugs are commonly used to treat rheumatoid arthr
itis patients, Their use in rheumatoid arthritis was discovered serend
ipitously and their modes of action remain unknown. This article revie
ws current hypotheses on the mechanisms of action of established DMARD
s, Most of them have anti-inflammatory properties and some are immunom
odulators, We also discuss a number of novel agents which are potentia
l new DMARDs.